No Data
No Data
William Blair Initiates Lyra Therapeutics(LYRA.US) With Hold Rating
Analysts Have Conflicting Sentiments on These Healthcare Companies: Arcus Biosciences (RCUS), ATyr Pharma (ATYR) and Lyra Therapeutics (LYRA)
Express News | HC Wainwright & Co. Reiterates Neutral on Lyra Therapeutics, Maintains $2 Price Target
Lyra Therapeutics Analyst Ratings
Lyra Therapeutics (LYRA) Gets a Hold From William Blair
Lyra Therapeutics FY 2024 GAAP EPS $(1.43) Misses $(1.38) Estimate, Sales $1.534M Beat $1.524M Estimate